The U.S. Food and Drug Administration (FDA) recently expanded clearance for Dexcom’s Stelo Glucose Biosensor System. Specifically, this device is now the first OTC glucose monitor available for pediatric patients. Therefore, children aged two and older who do not use insulin can track their blood sugar without a prescription. This option is particularly beneficial because pediatric prediabetes rates are currently rising.
Benefits of an OTC Glucose Monitor for Children
Managing pediatric diabetes requires continuous vigilance from parents and healthcare providers. Fortunately, this wearable sensor simplifies the tracking process by transmitting readings every 15 minutes. In addition, the system integrates seamlessly with smartphone applications. This real-time access allows caregivers to observe how meals and exercise affect a child’s glucose levels. Additionally, each sensor can last up to 15 days, although active pediatric wear times may sometimes be shorter.
Important Safety and Clinical Limitations
While this device offers incredible convenience, certain safety guidelines remain essential. For instance, the FDA emphasizes that children must use this device under direct adult supervision. Furthermore, users should always consult a healthcare provider before making any changes to their medication. For those looking to gain formal expertise in this area, specialized training is available through our international post-graduate program in pediatrics. Additionally, the manufacturer did not design the device for individuals with problematic low blood sugar. Because it lacks hypoglycemia alerts, patients at risk for severe low blood sugar should not rely on this system.
Frequently Asked Questions
Q1: Who is eligible to use the pediatric Stelo Glucose Biosensor System?
The FDA cleared the device for patients aged two and older who do not use insulin. Specifically, it works well for those using oral medications, a common treatment path often discussed in our master specialization in diabetes mellitus management.
Q2: Does the Stelo device alert users about dangerous low blood sugar levels?
No, this device does not alert users about problematic hypoglycemia. Therefore, individuals with severe low blood sugar concerns should not use it.
Q3: How long does each sensor last?
Each sensor can last up to 15 days. However, actual wear time in active children may be shorter.
References
- FDA clears first over-the-counter glucose monitor for children – ETHealthworld
- FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children – U.S. Food and Drug Administration
- Dexcom Stelo cleared as first OTC continuous glucose monitor for children – Healio / Pharmacally
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.